Margareta Hagman

M.Sc/Chief Financial Officer

Margareta holds an M.Sc. in Finance from Örebro University, Sweden. She has long experience from CFO roles and other positions in both listed and unlisted companies within the pharmaceutical and biotech industry. Notably, she has been the Executive Vice President and Chief Financial Officer (CFO) at BioGaia AB. Margareta has also been the CFO at Xbrane Biopharma AB and Ortivus AB and is a board member at Infant Bacterial Therapeutics AB – all companies listed on Nasdaq Stockholm..

Margareta joined Isofol in August 2024.

Position: Chief Financial Officer

Holdings*: 126,664 shares, 28,888 warrants serie TO1, 28,888 warrants serie TO2, 178 773 performance-based share rights 2025-2028

Contact:
E-mail: margareta.hagman@isofolmedical.com

*Own or related natural or legal person holding shares and other financial instruments in the company. Holdings as of July 31, 2025.